BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10869539)

  • 1. Beta(2)-adrenergic receptor overexpression driven by alpha-MHC promoter is downregulated in hypertrophied and failing myocardium.
    Sheridan DJ; Autelitano DJ; Wang B; Percy E; Woodcock EA; Du XJ
    Cardiovasc Res; 2000 Jul; 47(1):133-41. PubMed ID: 10869539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
    Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
    Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts.
    Wang BH; Du XJ; Autelitano DJ; Milano CA; Woodcock EA
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1079-86. PubMed ID: 10993770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.
    Lowes BD; Minobe W; Abraham WT; Rizeq MN; Bohlmeyer TJ; Quaife RA; Roden RL; Dutcher DL; Robertson AD; Voelkel NF; Badesch DB; Groves BM; Gilbert EM; Bristow MR
    J Clin Invest; 1997 Nov; 100(9):2315-24. PubMed ID: 9410910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis.
    Du XJ; Autelitano DJ; Dilley RJ; Wang B; Dart AM; Woodcock EA
    Circulation; 2000 Jan 4-11; 101(1):71-7. PubMed ID: 10618307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling.
    Akhter SA; Milano CA; Shotwell KF; Cho MC; Rockman HA; Lefkowitz RJ; Koch WJ
    J Biol Chem; 1997 Aug; 272(34):21253-9. PubMed ID: 9261135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted alpha(1A)-adrenergic receptor overexpression induces enhanced cardiac contractility but not hypertrophy.
    Lin F; Owens WA; Chen S; Stevens ME; Kesteven S; Arthur JF; Woodcock EA; Feneley MP; Graham RM
    Circ Res; 2001 Aug; 89(4):343-50. PubMed ID: 11509451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of beta-myosin heavy chain expression on cardiac function during stress.
    Krenz M; Robbins J
    J Am Coll Cardiol; 2004 Dec; 44(12):2390-7. PubMed ID: 15607403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac hypertrophy: old concepts, new perspectives.
    Gupta M; Gupta MP
    Mol Cell Biochem; 1997 Nov; 176(1-2):273-9. PubMed ID: 9406172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal regulation of β-myosin heavy chain expression in the mouse left ventricle.
    Patrizio M; Musumeci M; Piccone A; Raggi C; Mattei E; Marano G
    J Endocrinol; 2013 Mar; 216(3):287-96. PubMed ID: 23179080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
    Du XJ; Fang L; Gao XM; Kiriazis H; Feng X; Hotchkin E; Finch AM; Chaulet H; Graham RM
    J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific inhibition of kinase activity in calcium/calmodulin-dependent protein kinase kinase-β leads to accelerated left ventricular remodeling and heart failure after transverse aortic constriction in mice.
    Watanabe S; Horie T; Nagao K; Kuwabara Y; Baba O; Nishi H; Sowa N; Narazaki M; Matsuda T; Takemura G; Wada H; Hasegawa K; Kimura T; Ono K
    PLoS One; 2014; 9(9):e108201. PubMed ID: 25255457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological induction of a beta-adrenergic receptor kinase inhibitor transgene preserves ss-adrenergic responsiveness in pressure-overload cardiac hypertrophy.
    Manning BS; Shotwell K; Mao L; Rockman HA; Koch WJ
    Circulation; 2000 Nov; 102(22):2751-7. PubMed ID: 11094043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered cardiac hormone and contractile protein messenger RNA levels following left ventricular myocardial infarction in the rat: an in situ hybridization histochemical study.
    Young RL; Gundlach AL; Louis WJ
    Cardiovasc Res; 1998 Jan; 37(1):187-201. PubMed ID: 9539873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fat supply to failing hearts determines dynamic lipid signaling for nuclear receptor activation and oxidation of stored triglyceride.
    Lahey R; Wang X; Carley AN; Lewandowski ED
    Circulation; 2014 Nov; 130(20):1790-9. PubMed ID: 25266948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of protein phosphatase 1 by inhibitor-2 exacerbates progression of cardiac failure in a model with pressure overload.
    Grote-Wessels S; Baba HA; Boknik P; El-Armouche A; Fabritz L; Gillmann HJ; Kucerova D; Matus M; Müller FU; Neumann J; Schmitz M; Stümpel F; Theilmeier G; Wohlschlaeger J; Schmitz W; Kirchhefer U
    Cardiovasc Res; 2008 Aug; 79(3):464-71. PubMed ID: 18453636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB activation is required for adaptive cardiac hypertrophy.
    Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
    Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(salpha) mouse.
    Asai K; Yang GP; Geng YJ; Takagi G; Bishop S; Ishikawa Y; Shannon RP; Wagner TE; Vatner DE; Homcy CJ; Vatner SF
    J Clin Invest; 1999 Sep; 104(5):551-8. PubMed ID: 10487769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent β-adrenergic blockade downregulates the gene expression of β-myosin heavy chain in the mouse heart.
    Maccari S; Pace V; Barbagallo F; Stati T; Ambrosio C; Grò MC; Molinari P; Vezzi V; Catalano L; Matarrese P; Patrizio M; Rizzi R; Marano G
    Eur J Pharmacol; 2020 Sep; 882():173287. PubMed ID: 32585157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.